Patent · US Active

Anti-ANGPT2 antibodies

US11396539B2 · kind B2 · utility

0Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 2020
Grant dateJul 26, 2022
Priority date
Expiry dateJun 25, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to new anti-angiopoietin 2 (ANGPT2) neutralizing antibodies for therapeutic and diagnostic methods and composition using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.